Capital International Investors Sells 10,801,587 Shares of Corteva, Inc. $CTVA

Capital International Investors lessened its holdings in Corteva, Inc. (NYSE:CTVA) by 92.8% during the fourth quarter, HoldingsChannel reports. The fund owned 835,249 shares of the company’s stock after selling 10,801,587 shares during the quarter. Capital International Investors’ holdings in Corteva were worth $55,987,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in CTVA. JPL Wealth Management LLC acquired a new stake in shares of Corteva in the 3rd quarter worth about $25,000. Redmont Wealth Advisors LLC acquired a new stake in shares of Corteva in the 3rd quarter worth about $29,000. Jackson Grant Investment Advisers Inc. raised its holdings in shares of Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after acquiring an additional 213 shares during the last quarter. Basepoint Wealth LLC acquired a new stake in shares of Corteva in the 4th quarter worth about $30,000. Finally, KERR FINANCIAL PLANNING Corp acquired a new stake in shares of Corteva in the 3rd quarter worth about $33,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Down 1.3%

Shares of CTVA stock opened at $76.04 on Tuesday. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The company has a 50-day simple moving average of $81.03 and a two-hundred day simple moving average of $75.09. The company has a market capitalization of $50.86 billion, a price-to-earnings ratio of 44.73, a PEG ratio of 2.36 and a beta of 0.57.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the prior year, the firm posted $1.13 EPS. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio is presently 42.35%.

Wall Street Analyst Weigh In

CTVA has been the topic of a number of analyst reports. UBS Group upped their target price on shares of Corteva from $88.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Oppenheimer upped their target price on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Morgan Stanley upped their target price on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Argus upped their target price on shares of Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, March 31st. Finally, Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.